Genetic susceptibility to cerebrovascular disease

David Della-Morte1, Francesca Pacifici, Tatjana Rundek

  • 1aDepartment of Neurology, Miller School of Medicine, University of Miami, Miami, Florida, USA bDepartment of Systems Medicine, School of Medicine, University of Rome Tor Vergata cIRCCS San Raffaele Pisana, Rome, Italy.

Insights

Genetic factors significantly influence cerebrovascular disease (CeVD) risk, beyond traditional factors. Understanding gene-lipid interactions is key to developing personalized CeVD prevention strategies.

Area of Science:

  • Neurology
  • Genetics
  • Cardiovascular Science

Background:

  • Cerebrovascular disease (CeVD) is a leading global cause of death and disability.
  • CeVD arises from complex interactions between vascular risk factors, environmental influences, and genetic predispositions.
  • Genetic susceptibility plays a crucial role in the pathogenesis of CeVD.

Purpose of the Study:

  • To review genetic susceptibility to CeVD.
  • To emphasize genetic studies linking lipid traits and CeVD.
  • To explore novel genetic determinants impacting CeVD.

Main Methods:

  • Review of animal and clinical studies on genetic predisposition to atherosclerosis and CeVD.
  • Analysis of genome-wide technology findings implicating novel genetic variants.
  • Examination of studies on genes like PCSK9 in stroke and familial hypercholesterolemia.

Main Results:

  • Genetic predisposition to atherosclerosis and CeVD, especially ischemic stroke, is well-established.
  • Traditional vascular risk factors explain limited variance in atherosclerosis; novel genetic factors are significant.
  • Genome-wide studies identified genetic variants in CeVD and lipid metabolism, including the PCSK9 gene.

Conclusions:

  • Genetics is integral to CeVD pathogenesis, involving complex gene-gene and gene-environment interactions.
  • Lipid metabolism genes are critical for individual susceptibility to CeVD.
  • Incorporating genetic, environmental, and lifestyle variations advances precision medicine for CeVD treatment and prevention.
Abstract

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
108
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
87
Genetic Lingo01:11

Genetic Lingo

Overview
117.3K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.6K